Novartis' Glivec extends European GIST licence

Novartis&#39 Glivec extends European GIST licence
Novartis&#39 cancer therapy Glivec (imatinib) can now be used in Europe to treat specific patients with gastrointestinal stromal tumours (GIST) up to 3 years right after surgery. The European Commission (EC) has approved an update to the labelling for the …
Read much more on PMLiVE

Positive Vote for Glaxo&#39s Votrient
Patients with gastrointestinal stromal tumours (GIST) and adipocytic sarcomas were not included in this trial. The study information demonstrated that median progression totally free survival amongst patients receiving Votrient was four.6 months compared to 1.five months …
Read far more on

Paul Allen&#39s Huge Bet to &#39Uncover the Essence of What Tends to make Us Human&#39
Paul Allen, chatting with Larry Corey, the president of the Fred Hutchinson Cancer Study Center, right after the press conference. For those who missed the story yesterday, right here&#39s the gist. The Allen Institute will roughly double in size, from 185 people …
Read more on Xconomy